CND Life Sciences announces baseline results from Syn-Sleep Study to be presented at SLEEP 2025. iRBD is a sleep disorder that causes affected individuals to act out their dreams, often with violent ...
SCOTTSDALE, Ariz., Oct. 7, 2025 /PRNewswire/ -- CND Life Sciences, Inc. (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results